Opinion|Videos|May 9, 2025
Final Thoughts Alzheimer Disease Care
Panelists discuss how the current Alzheimer disease treatment landscape represents both significant progress with novel amyloid-targeting therapies and ongoing challenges, while expressing hope for future advances including more potent disease-modifying treatments, combination therapies, earlier intervention capabilities, improved biomarkers, greater health care equity, and comprehensive care models that address both medical and psychosocial aspects of the disease.
Advertisement
Video content above is prompted by the following:
- What strategies can clinicians and health systems use to navigate coverage challenges and ensure eligible patients receive timely treatment?
- How does the limited number of neurologists in the United States impact patient care?
- What could be done to help address this shortage? (For example: Could advanced practice providers help fill this gap, and what would be needed to prepare them for this role?)
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
ATTR-CM Incidence, Prevalence Rose Sharply in the US
2
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
3
Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC
4
First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention
5